Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(ferric citrate)
1,172 results
  • Effect of four kinds of complexing iron on the process of iron uptake by Anabaena flos-aquae. [Journal Article]
    Microbiology 2020Qiu Y, Wang Z, … Liu J
  • AbstractIron (Fe), which is a necessary micronutrient for algal growth, plays an important role in the physiological metabolism and enzymatic reactions of algae. This study aimed to investigate the absorption process of four kinds of complexing iron absorbed by Anabaena flos-aquae. Results showed that the absorptive capacity of A. flos-aquae to complex iron was inversely proportional to the stabi…
  • Novel Tat-dependent protein secretion. [Journal Article]
    J Bacteriol 2020Braun V, Hantke K
  • The transcription initiation signal elicited by the binding of ferric citrate to the outer membrane FecA protein is transmitted by the FecR protein across the cytoplasmic membrane to the FecI extra cytoplasmic function (ECF) sigma factor. Recently, Passmore et al. (1) reported that the FecR sequence contains both the twin arginine signal motif and the Sec avoidance motif typical of proteins secre…
  • Can ferric citrate lead to iron overload in peritoneal dialysis patients? . [Journal Article]
    Clin Nephrol 2020Aslam N, Govani M, … Wadei HM
  • Ferric citrate (FC), a novel oral phosphate binder, is approved by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in end-stage renal disease (ESRD) patients receiving dialysis. FC binds to dietary phosphate in the gastrointestinal (GI) tract producing ferric phosphate that is excreted in feces. However, a small quantity of iron is systemically absorbed. There a…
  • Phosphate binders in chronic kidney disease: an updated narrative review of recent data. [Review]
    J Nephrol 2019Floege J
  • Chronic kidney disease (CKD) is frequently accompanied by hyperphosphatemia. High serum phosphate usually requires dietary measures, adequate dialysis prescription and/or phosphate binders. For this narrative review a PubMed searched was undertaken to identify new publications on phosphate binders that had been published between January 2015 and July 2019. The present review summarizes this most …
New Search Next